Subtopic Deep Dive
SARS-CoV-2 spike-ACE2 receptor binding
Research Guide
What is SARS-CoV-2 spike-ACE2 receptor binding?
SARS-CoV-2 spike-ACE2 receptor binding refers to the molecular interaction between the viral spike protein's receptor-binding domain (RBD) and the human ACE2 receptor that mediates host cell entry.
Cryo-EM and X-ray crystallography structures revealed key contact residues in the RBD-ACE2 interface (Lan et al., 2020; Shang et al., 2020). Over 6600 papers cite the first RBD-ACE2 complex structure, with mutations like D614G enhancing binding affinity (Korber et al., 2020). Studies focus on variant escape and therapeutic decoys.
Why It Matters
Precise mapping of spike-ACE2 contacts guides neutralizing antibody design, as shown in Walls et al. (2020) with 8959 citations analyzing spike antigenicity. Variant mutations altering binding inform vaccine updates (Korber et al., 2020). Receptor decoys and inhibitors target this interface for COVID-19 therapies (Jackson et al., 2021).
Key Research Challenges
Variant Escape Mutations
SARS-CoV-2 variants like D614G increase infectivity by stabilizing RBD-ACE2 binding (Korber et al., 2020). Predicting escape from antibodies requires modeling dynamic interfaces. Over 4400 citations highlight ongoing evolution challenges.
Antibody Epitope Mapping
Neutralizing epitopes overlap with ACE2 site, complicating broad immunity (Walls et al., 2020). Cryo-EM identifies conformational changes post-binding (Shang et al., 2020). High citation counts (8959 for Walls) underscore verification needs.
Therapeutic Decoy Design
Engineered ACE2 decoys must mimic native binding without toxicity (Lan et al., 2020). Structural proteomics informs inhibition strategies (Bartlam et al., 2007). Entry mechanisms demand multi-site targeting (Jackson et al., 2021).
Essential Papers
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · 2020 · Cell · 9.0K citations
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan, Jiwan Ge, Jinfang Yu et al. · 2020 · Nature · 6.6K citations
Origin and evolution of pathogenic coronaviruses
Jie Cui, Fang Li, Zheng‐Li Shi · 2018 · Nature Reviews Microbiology · 5.8K citations
Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are two highly transmissible and pathogenic viruses that emerged in humans at th...
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou et al. · 2020 · Nature Reviews Microbiology · 5.3K citations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, n...
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong et al. · 2020 · Military Medical Research · 4.9K citations
Abstract An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received wo...
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia et al. · 2020 · Nature reviews. Immunology · 4.6K citations
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber, Will Fischer, S. Gnanakaran et al. · 2020 · Cell · 4.4K citations
Reading Guide
Foundational Papers
Start with Lan et al. (2020) for initial RBD-ACE2 structure (6603 citations), then Walls et al. (2020) for antigenicity context (8959 citations); pre-2015 Beniac et al. (2007) explains conformational changes in SARS-CoV spike.
Recent Advances
Korber et al. (2020) on D614G infectivity (4404 citations); Jackson et al. (2021) on entry mechanisms; Shang et al. (2020) for recognition details.
Core Methods
Cryo-EM for complexes (Lan et al., 2020); X-ray crystallography for epitopes (Shang et al., 2020); mutagenesis and binding assays for variants (Korber et al., 2020).
How PapersFlow Helps You Research SARS-CoV-2 spike-ACE2 receptor binding
Discover & Search
Research Agent uses searchPapers and exaSearch to find 6603-citation Lan et al. (2020) RBD-ACE2 structure, then citationGraph reveals downstream variant studies like Korber et al. (2020). findSimilarPapers expands to Shang et al. (2020) for comparative interfaces.
Analyze & Verify
Analysis Agent applies readPaperContent to extract binding residues from Walls et al. (2020), verifies claims with CoVe against 250M+ OpenAlex papers, and runs PythonAnalysis for affinity scoring via NumPy on mutation data. GRADE grading scores evidence strength for D614G claims (Korber et al., 2020).
Synthesize & Write
Synthesis Agent detects gaps in variant escape coverage across Lan et al. (2020) and Korber et al. (2020), flags contradictions in epitope data. Writing Agent uses latexEditText, latexSyncCitations for Walls et al. (2020), and latexCompile for structural figures; exportMermaid diagrams RBD-ACE2 interfaces.
Use Cases
"Analyze D614G mutation effects on ACE2 binding affinity from Korber et al."
Research Agent → searchPapers('D614G ACE2') → Analysis Agent → readPaperContent(Korber 2020) → runPythonAnalysis(pandas plot of mutation scores) → matplotlib infectivity graph output.
"Draft LaTeX review of spike-ACE2 cryo-EM structures."
Synthesis Agent → gap detection(Lan 2020, Shang 2020) → Writing Agent → latexEditText(structural summary) → latexSyncCitations(Walls 2020) → latexCompile → PDF with embedded figures.
"Find code for RBD-ACE2 docking simulations."
Research Agent → paperExtractUrls(Shang 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for interface modeling.
Automated Workflows
Deep Research workflow scans 50+ papers from citationGraph of Lan et al. (2020), outputs structured report on binding evolution with GRADE scores. DeepScan's 7-step chain verifies Korber et al. (2020) D614G claims via CoVe checkpoints and runPythonAnalysis. Theorizer generates hypotheses on decoy designs from Walls et al. (2020) and Jackson et al. (2021).
Frequently Asked Questions
What defines SARS-CoV-2 spike-ACE2 binding?
It is the RBD-ACE2 interface interaction enabling viral entry, first structurally resolved by Lan et al. (2020, Nature, 6603 citations).
What methods study this interaction?
Cryo-EM and crystallography map residues (Lan et al., 2020; Shang et al., 2020); computational docking simulates mutations (Korber et al., 2020).
What are key papers?
Walls et al. (2020, Cell, 8959 citations) on spike antigenicity; Lan et al. (2020, Nature, 6603 citations) on RBD-ACE2 structure; Shang et al. (2020, Nature, 3999 citations) on recognition basis.
What open problems exist?
Predicting broad variant escape (Korber et al., 2020); designing non-toxic ACE2 decoys (Jackson et al., 2021); modeling post-binding fusion (Beniac et al., 2007).
Research SARS-CoV-2 and COVID-19 Research with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching SARS-CoV-2 spike-ACE2 receptor binding with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the SARS-CoV-2 and COVID-19 Research Research Guide